BREAKING: Stock Market Hits Record Highs After Cool CPI After peaking in February 2021, biotech stocks as a group didn't participate once the market turned around after 2022. This summer seems to have changed that. Biotech stocks are not easy to handle individually. The development stage cohort is filled with stocks that have no earnings and often no revenue, except for inconsistent milestone payments. That just happens to be the majority of members in the nearly 800 stock Medical-Biomed/Biotech group. But ...

公司销售表现 - Geron Corporation的Rytelo (imetelstat)自2025年中推出以来仅报告了两个完整季度的销售数据 [1] - 该产品的市场推出似乎出现平台期 可能引发市场担忧 [1] 行业背景 - 行业受FDA监管 重点关注临床试验结果和新药申请/生物制剂许可申请(NDA/BLA)的审批进展 [1]